Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer

Published:2018-11 Issue:46 Volume:97 Page:e13204
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Gong Ping,Liu Hongjian,Liu Xinyu,Zhou Ge,Liu Meitian,Yang Xiaodi,Xiong Wenjing,Wang Qi,Ma Juan,Ren Zheng,He Minfu,Zhang Xiumin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC cancer base no. 10;Ferlay;Int J Cancer,2012

2. Global cancer statistics;Ahmedin;CA Cancer J Clin,1900

3. Global patterns of cancer incidence and mortality rates and trends;Jemal;Cancer Epidemiol Biomarkers Prev,2010

4. Characterising the castration-resistant prostate cancer population: a systematic review;Kirby;Int J Clin Pract,2011

5. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline;Loblaw;J Clin Oncol,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint Inhibitors;Cancers;2024-07-10

2. Third generation quinoline‐3‐carboxamide transcriptional disrupter of HDAC4, HIF‐1α, and MEF‐2 signaling for metastatic castration‐resistant prostate cancer;The Prostate;2023-08-09

3. Targeting Angiogenesis in Cancer Therapy;2023

4. Carboxamide Derivatives Are Potential Therapeutic AHR Ligands for Restoring IL-4 Mediated Repression of Epidermal Differentiation Proteins;International Journal of Molecular Sciences;2022-02-04

5. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target;Cell Death & Disease;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3